Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares dipped 4.02% in after-hours trading on Monday, July 7, 2025, settling at $9.07 soon after the filing of $25 million share offering.
Helius Medical Technologies (HMTI) filed an updated Prospectus Supplement for the offer and sale of up to $25 million of shares through the Agent pursuant to the Sales Agreement. On June 23, 2023, Helius Medical Technologies, Inc. entered into a Sales Agreement with Roth Capital Partners, LLC, as sales agent. Pursuant to this agreement, the company may offer and sell shares of its common stock. Helius Medical Technologies plans to utilize the net proceeds from the offering for working capital and general corporate purposes.
The stock initially opened at $9.20, oscillating between $8.90 and $9.70, It had concluded regular trading at $9.45, together with a trading volume of 68.60 thousand shares.
